Nava Sarver
- Molecular Biology top 5%
- Genetics top 5%
- Virology top 1%
- Infectious Diseases top 5%
- Epidemiology top 10%
- Co-authors
- Peter M. HowleyJohn J. RossiJ C ByrneEdouard M. CantinPaula LadneJohn A. ZaiaVictor StollarMing-Fan Law
- Topics
- Virus-based gene therapy research (13 papers)HIV Research and Treatment (13 papers)RNA and protein synthesis mechanisms (10 papers)
- Cited by
- VirologyGeneticsInfectious Diseases
- Partner nations
- United StatesBulgariaIsrael
In The Last Decade
Nava Sarver
38 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Molecular Biology 1.4k
- Genetics 653
- Virology 614
- Infectious Diseases 427
- Epidemiology 399
Countries citing papers authored by Nava Sarver
This map shows the geographic impact of Nava Sarver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nava Sarver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nava Sarver more than expected).
Fields of papers citing papers by Nava Sarver
This network shows the impact of papers produced by Nava Sarver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nava Sarver. The network helps show where Nava Sarver may publish in the future.
Co-authorship network of co-authors of Nava Sarver
This figure shows the co-authorship network connecting the top 25 collaborators of Nava Sarver. A scholar is included among the top collaborators of Nava Sarver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nava Sarver. Nava Sarver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 54 | |
| 3 | 20 | |
| 4 | 4 | |
| 5 | 55 | |
| 6 | 50 | |
| 7 | 25 | |
| 8 | 14 | |
| 9 | 12 | |
| 10 | 0 | |
| 11 | 22 | |
| 12 | 7 | |
| 13 | 10 | |
| 14 | 30 | |
| 15 | 11 | |
| 16 | 47 | |
| 17 | 42 | |
| 18 | 132 | |
| 19 | 22 | |
| 20 | 5 |
About Nava Sarver
Nava Sarver is a scholar working on Virology, Infectious Diseases and Genetics, having authored 39 papers that have together received 2.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (13 papers), HIV Research and Treatment (13 papers) and RNA and protein synthesis mechanisms (10 papers). The work is most often cited by research in Virology (614 citations), Genetics (653 citations) and Infectious Diseases (427 citations). Nava Sarver has collaborated with scholars based in United States, Bulgaria and Israel. Frequent co-authors include Peter M. Howley, John J. Rossi, J C Byrne, Edouard M. Cantin, Paula Ladne, John A. Zaia, Victor Stollar, Ming-Fan Law, Sandra H. Bridges and Joseph Schlessinger. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.